In Brief
Otx2 induction is required for the reorganization of Oct4 during the transition from naive to primed pluripotency. Williams et al. show that Sirt1 deacetylates Oct4 in the naive state, preventing Oct4-dependent induction of Otx2, thus inhibiting the induction of primed pluripotency.
INTRODUCTION
During embryogenesis, an exquisite program of ordered events enables a single zygote to develop into a multicellular organism with diverse cell types. A critical step in this process is the ability of pluripotent epiblast cells to coordinate the balance between self-renewal and lineage specification (Kunath et al., 2007; Niwa, 2007; . This task is thought to be at least partially accomplished by the transition of these cells through at least two distinct pluripotent states (Brons et al., 2007; Tesar et al., 2007) .
Pre-implantation epiblast cells exhibit naive or ground state pluripotency. This state has been defined as fully unrestricted with the ability to contribute to all embryonic lineages Rossant, 2008) . Embryonic stem cell lines derived from pre-implantation mouse blastocysts exhibit characteristics of naive pluripotency (Evans and Kaufman, 1981; Nichols and Smith, 2011) . These include a rounded morphology, the maintenance of self-renewal through Jak/Stat3 and Bmp4 (Matsuda et al., 1999; Niwa et al., 2009; Ying et al., 2003) , single-cell clonogenicity, and efficient contribution to chimeras (Han et al., 2010) .
During embryo implantation, cells of the epiblast layer transition from the naive state to the primed pluripotency state (Arnold and Robertson, 2009; Brons et al., 2007; Kojima et al., 2014; Tesar et al., 2007) . While still capable of contributing to all three germ lineages, primed epiblast stem cells are thought to be more developmentally restricted than naive embryonic stem cells (ESCs), and they undergo X chromosome inactivation (Bao et al., 2009; Guo et al., 2009; Heard, 2004; . Indeed, chimeric contribution of pluripotent primed cells is significantly less efficient than that of pluripotent naive cells (Brons et al., 2007; Han et al., 2010; Tesar et al., 2007) . Primed cells can be cultured by obtaining epiblast cells of the early post-implantation mouse embryo (Nichols and Smith, 2011) . The primed state also can be induced in vitro by the addition of Fgf and Activin A to naive cells (Brons et al., 2007; Tesar et al., 2007; Thomson et al., 1998) . In the primed state, cultured stem cells are morphologically flat and exhibit low single-cell clonogenicity.
Interestingly, human embryonic stem cells derived from preimplantation blastocysts resemble primed murine stem cells more than naive cells (Brons et al., 2007; Rossant, 2008; Tesar et al., 2007) . In addition, human induced pluripotent stem cells (iPSCs) exhibit features of the primed state of pluripotency (Takahashi et al., 2007; Yu et al., 2007) , while mouse iPSCs naturally revert to the naive state (Takahashi and Yamanaka, 2006) . While the reasons for these mouse-human differences remain unclear, there are a number of practical advantages that make the naive state a more desirable research tool. Pluripotent naive stem cells are characterized by a more open chromatin structure (Murtha et al., 2015) , allowing for more efficient genetic manipulation (Buecker et al., 2010; Zwaka and Thomson, 2003) . In addition primed cells are prone to greater heterogeneity in gene expression (Bernemann et al., 2011; Gafni et al., 2013; Osafune et al., 2008) , making it difficult to obtain unbiased lineage-specific specification. Lastly, naive human embryonic stem cells are capable of contributing to cross-species chimeras (Gafni et al., 2013) , a tool that will likely be useful for the creation of humanized animal models. Several attempts have been made to stably reprogram human embryonic stem cells to the naive state using both genetic (Takashima et al., 2014; Wang et al., 2011) and chemical methodologies (Chan et al., 2013; Duggal et al., 2015; Gafni et al., 2013; Hanna et al., 2010; Theunissen et al., 2014; Valamehr et al., 2014; Ware et al., 2014) . These studies have been met with varying levels of success, but the robustness of these protocols with regard to the long-term culture of the naive state is still being evaluated (Dodsworth et al., 2015) .
Understanding the molecular mechanisms driving the naiveto-primed transition is crucial for comprehending the regulation of mammalian development and the optimization of experimental protocols for stem cell therapy. One important observation is the dramatic difference in the enhancer chromatin landscape between the naive and primed states (Buecker et al., 2014; Factor et al., 2014; Sohni et al., 2015; Tesar et al., 2007; Yang et al., 2014; Yeom et al., 1996) . Indeed, recent epigenomic analysis concluded that enhancer usage is the most distinguishing factor between these two states. Interestingly, enhancer usage changes are observed in both differentially expressed genes and in genes with similar expression levels between these two states (Factor et al., 2014 ). An example is Oct4, a transcription factor whose expression levels promote self-renewal and inhibit differentiation of stem cells (Nichols et al., 1998; Radzisheuskaya et al., 2013) . Oct4 enhancer activity shifts from a distal enhancer dependent on Oct4 itself in naive cells to a proximal, Oct4-independent enhancer in primed cells, without affecting the total expression level of the gene (Buecker et al., 2014; Yang et al., 2014) .
Oct4 reorganization is driven by the upregulation of the transcription factor Otx2 early in the transition from naive to primed states. Oct4 is required for the early upregulation of Otx2, and Otx2 is required for the recruitment of Oct4 to primed enhancers (Acampora et al., 2013; Buecker et al., 2014; Yang et al., 2014) . Importantly, the induction of Otx2 expression by Oct4 is sufficient to induce the transition from the naive to the primed state (Buecker et al., 2014; Yang et al., 2014) .
Here we find that Oct4 is post-translationally modified by acetylation in mouse embryonic stem cells and that Oct4 acetylation status is a key component of the naive-to-primed transition. During this transition, activity of the NAD+-dependent deacetylase SirT1 decreases, and, concomitantly, the acetylation of Oct4 increases. Indeed, knocking out SirT1 in naive ESCs increases Oct4 acetylation and results in the partial upregulation of the primed pluripotency network. Importantly, the hyper-acetylated Oct4 in SirT1-knockout ESCs displays increased occupancy at an Otx2 enhancer element and, thus, induces Otx2 expression. Inactivation of SirT1 in wild-type ESCs therefore provides a mechanism for the induction of Otx2 early in the naive-to-primed transition. Lastly, knocking down Otx2 expression in SirT1-knockout cells reverses the induction of the primed network, thus linking the SirT1-Oct4-Otx2 axis to the naive-to-primed transition of epiblasts.
RESULTS

SirT1
Activity Decreases during the Transition from Naive to Primed Pluripotency Previous reports indicate that SirT1 is expressed at high levels in pluripotent stem cells and these levels decline considerably during lineage specification (Calvanese et al., 2010; McBurney et al., 2003a McBurney et al., , 2003b Sakamoto et al., 2004) . We decided to use mouse embryoid bodies to model the differentiation that normally occurs in early post-implantation embryos (Desbaillets et al., 2000) . Consistent with previous findings, we observed a decrease in SirT1 protein levels as pluripotent mouse embryonic stem cells transitioned from self-renewal (high Oct4 expression) toward lineage specification (low Oct4 expression) ( Figure 1A) .
Interestingly, the levels of SirT1 protein closely mimicked that of Oct4, the master pluripotency transcription factor ( Figure 1A) . To determine the extent of SirT1/Oct4 co-regulation, we performed immunocytochemistry in mouse embryonic stem cells grown in serum/LIF conditions. Mouse embryonic stem cells grown in serum/LIF exist in multiple stages of pluripotency and exhibit heterogeneous transcription factor expression (TorresPadilla and Chambers, 2014; Ying et al., 2008) . We identified colonies within our cultures with heterogeneous expression of Oct4. We observed that cells expressing the highest levels of Oct4 also had the highest levels of SirT1 expression ( Figure 1B , yellow arrows). Conversely, cells with lower expression of Oct4 also had low levels of SirT1 ( Figure 1B , white arrows), indicating a degree of co-regulation between SirT1 and Oct4. This may be a conserved mechanism between humans and mice, as loss of Oct4 expression in human embryonic stem cells also has been reported to reduce SirT1 expression (Zhang et al., 2014) . We also found that SirT1 is localized within the nucleus, as evidenced by its colocalization with DAPI and the activating histone modification (H3K4me 3 ) (Heintzman et al., 2007) ( Figure 1D ). No
SirT1 signal was detected in SirT1-null embryonic stem cells, demonstrating the specificity of the antibody ( Figure 1B ). To assess SirT1 expression during the naive-to-primed transition, we employed the previously described epiblast-like cell (EpiLC) differentiation protocol (Buecker et al., 2014; Hayashi et al., 2011; Yang et al., 2014) . Mouse embryonic stem cells were grown under serum-free 2i LIF conditions (MEK/ERK inhibitor, GSK3b inhibitor, and recombinant mouse LIF) to promote the naive state. Primed pluripotency was induced by stimulating with Fgf2 and Activin A. Within 48 hr, naive embryonic stem cells transitioned to primed EpiLCs. Consistent with previous studies, we found little to no change in Oct4 expression but dramatically reduced expression of Nanog in the primed state (Silva et al., 2009) (Figure 1C ). Genome-wide transcriptional analysis of naive ESCs and EpiLCs revealed significant overlap with previously characterized primed pluripotency datasets (Kim et al., 2013; Buecker et al., 2014) (Figures S1A-S1D ). While SirT1 levels remained unchanged between the two states, SirT1 activity was significantly reduced in primed EpiLCs. p53, a canonical target of SirT1 deacetylation (Vaziri et al., 2001) , was found to be hyper-acetylated at Lysine 379 in EpiLCs ( Figure 1C ), indicating a reduction in SirT1 activity during the transition to primed pluripotency. Quantification of p53 acetylation levels revealed a 1.67-to 1.95-fold increase in EpiLCs ( Figure S1E ). To confirm SirT1 dependence of p53 acetylation in ESCs, we tested p53 acetylation in SirT1-null and wild-type ESCs grown in naive conditions (2i + LIF). p53 was found to be 1.63-to 2.11-fold more acetylated in SirT1-null ESCs ( Figure S1F ). To rule out the possibility that decreased HDAC1 levels in EpiLCs and SirT1-null ESCs could be causing increased p53 acetylation at lysine 379 (Ito et al., 2002) , we performed western blots on HDAC1. We found no difference in HDAC1 protein levels among wild-type ESCs, SirT1-null ESCs, and EpiLCs ( Figure S1G ).
Interacts with and Deacetylates Oct4 in the Naive State To gain insights into the function of SirT1 in naive pluripotency, we assessed SirT1 occupancy at Oct4 enhancer domains. The regulation of Oct4 expression within the naive and primed states is well characterized. Activation of the Oct4 distal enhancer is associated with the promotion of the naive state, while Oct4 proximal enhancer activity is associated with primed pluripotency (Tesar et al., 2007; Theunissen et al., 2014; Yeom et al., 1996) (Figure 2A ). Chromatin immunoprecipitation (ChIP)-qPCR analysis of these enhancer regions revealed an enrichment of SirT1 protein within the distal enhancer of Oct4 in naive ESCs ( Figure 2B ). Interestingly, the enrichment of SirT1 was strongest at region 3, which previously was characterized to have strong Oct4/Sox2 binding (Chew et al., 2005) . Indeed, ChIP qPCR of Oct4 and Sox2 revealed similar occupancy patterns as SirT1 ( Figure 2C ).
To determine if SirT1 physically interacts with the Oct4 complex, we performed co-immunoprecipitation (coIP) experiments. Lysates prepared from mouse embryonic stem cells grown in naive conditions were immunopurified with a SirT1 antibody. Immunoblotting with an Oct4 antibody revealed Oct4 coIP (Figure 2D ). SirT1-Oct4 coIP was not observed in SirT1-null cells, verifying the specificity of the interaction ( Figure 2D ). Conversely, immunopurification of Oct4 yielded the coIP of SirT1. This signal also was abolished in SirT1-null cells ( Figure 2D ). To determine if Oct4 is a target of SirT1-mediated deacetylation, we used a pan-acetyl lysine antibody to assess Oct4 acetylation in Oct4-immunopurified lysates. This analysis revealed that Oct4 is hyper-acetylated in SirT1-null cells compared to wild-type cells ( Figure 2D ). Quantification of Oct4 acetylation levels revealed a 1.45-fold increase in the SirT1-null ESCs ( Figure S2A ). with the observed reduction in SirT1 activity in primed EpiLCs ( Figure 1C ), we found that Oct4 acetylation levels increased during the transition to primed EpiLCs ( Figure 2E ). Quantification of Oct4 acetylation levels revealed a 1.39-to 1.64-fold increase in acetylation in EpiLCs ( Figure S2B ). To rule out the possibility that HATs or other deacetylases present in the primed state resulted in the increased Oct4 acetylation, we assessed whether SirT1 could deacetylate Oct4 in transfected HEK293T cells. Myc-tagged Oct4, SirT1, and catalytically inactive SirT1 H355A (Rodgers et al., 2005) were co-transfected. Co-expression of SirT1, but not catalytically inactive SirT1
H355A , reduced Oct4 acetylation in transfected HEK293T cells ( Figure 2F ). Collectively, these results suggest that Oct4 is a direct target of SirT1-mediated deacetylation in naive cells and that Oct4 acetylation increases in EpiLCs due to decreased activity of SirT1.
Loss of SirT1 in the Naive State Induces Partial Activation of the Primed Pluripotency Network Morphologically, SirT1-knockout ESCs were found to adopt a slightly flatter morphology when grown in 2i LIF, but they were indistinguishable from wild-type cells when grown in serum with mouse embryonic fibroblasts (MEFs) (data not shown). The cellautonomous growth rate of SirT1-knockout ESCs was found to be slightly slower than wild-type cells ( Figure S3A ), but no observable differences were identified in apoptosis or cell-cycle progression ( Figures S3B-S3D ).
Clonogenicity is a distinguishing factor between the naive and primed states. Naive ESCs are able to form colonies from single ESCs, while single primed cells either differentiate or undergo apoptosis (Brons et al., 2007; Tesar et al., 2007) . We found that SirT1-knockout ESCs exhibited similar clonogenicity as wildtype when grown in naive conditions. However, SirT1-knockout ESCs lost clonogenicity faster than wild-type ESCs during the transition from the naive state to the primed state ( Figure S3E ). In addition, loss of SirT1 inhibited the reprogramming of primed cells to the naive state as measured by clonogenicity (Figure S3F ). To determine if the SirT1-Oct4 interaction might play a role in the regulation of pluripotency networks, we performed RNA sequencing (RNA-seq) transcriptome analysis in SirT1-null embryonic stem cells. Wild-type and SirT1-null ESCs were grown in naive conditions. In addition, wild-type cells were differentiated into EpiLCs in order to define gene networks induced during the naive-to-primed transition. We identified 2,616 genes as significantly differentially expressed between the naive and primed EpiLC states. These primed genes exhibited extensive overlap with previously published datasets (Buecker et al., 2014; Kim et al., 2013) (Figures S1A-S1D) . Comparison of wild-type naive and SirT1-null embryonic stem cells revealed 1,535 differentially expressed genes. Of these genes, 931 overlapped with the differential expression observed during the transition from wild-type naive ESCs to wild-type primed EpiLCs. Similar overlap also was observed between the expression changes induced by the loss of SirT1 and previously published datasets comparing the naive and primed states (Buecker et al., 2014; Kim et al., 2013) (Figure 3A) . The positive correlation between the gene network induced during the transition from naive to primed EpiLCs and the expression changes caused by the loss of SirT1 had a Pearson product-moment correlation coefficient of R = 0.669 ( Figure 3B ).
Consistent with a shift toward primed pluripotency in SirT1-null ESCs, our RNA-seq analysis revealed changes in the expression of important markers of primed pluripotency. These included the downregulation of Nanog and Klf2 (Silva et al., 2009; Yeo et al., 2014) , upregulation of Fgf5 and Otx2 (Acampora et al., 2013; Buecker et al., 2014; Nichols and Smith, 2009; Yang et al., 2014) , and the maintenance of Oct4 expression levels between the two states. The expression changes of primed markers were confirmed by qRT-PCR ( Figure S4A ). In addition, Wild-type ESCs (blue), SirT1-knockout ESCs (red), and wild-type ESCs treated with 1 mM Ex-527 for 48 hr (purple) were analyzed after IP with Oct4 antibody (left, Oct4 enhancer regions, as described in Figure 2A ; right, Otx2 enhancer regions). Student's t tests with a p value less than 0.05 are indicated. Error bars represent SEM.
(legend continued on next page)
western blots were performed in both SirT1-null and homozygous SirT1
DEx4 ESCs. To acutely remove exon 4 of SirT1, a domain required for SirT1 deacetylase activity (Cheng et al., 2003) , we employed a tamoxifen-inducible cre. Using fluorescent reporters, we estimated that 90%-95% of cells excised exon 4 of SirT1 (data not shown). In all samples with SirT1 deleted, there were reductions in Nanog and Klf2 proteins and increases in Fgf5 and Otx2 proteins ( Figure 3C ). These data indicate that the loss of SirT1 induces gene expression changes consistent with the induction of the primed pluripotency gene network.
Loss of SirT1 Causes Oct4 Reorganization at Naive and Primed Enhancers
The shift from naive to primed pluripotency is characterized by a dramatic reorganization of Oct4 occupancy at enhancer regions (Buecker et al., 2014; Factor et al., 2014; Yang et al., 2014 (Tesar et al., 2007; Yeom et al., 1996) . Consistent with previous findings, the distal enhancer of Oct4 was more active in the naive state than in the primed state. Moreover, the distal enhancer of Oct4 was less active in SirT1-knockout ESCs grown in naive conditions ( Figure 4B ; Figure S4B ), indicating that the loss of Oct4 binding results in decreased Oct4 distal enhancer activity. Under conditions of primed pluripotency, the loss of Oct4 distal enhancer activity is compensated for by increased activity of the proximal enhancer, thus maintaining equivalent expression levels of Oct4 (Tesar et al., 2007) . Likewise, the proximal enhancer activity of Oct4 was increased in SirT1-knockout cells ( Figure 4B ), thus helping to maintain the levels of Oct4 expression ( Figures 3C and 4C ). In support of these data, loss of SirT1 also facilitated changes in activities of the distal and proximal enhancers during the naive-to-primed transition, and it inhibited the reverse changes during the primed-to-naive transition ( Figure S4B ). An early event in Oct4 reorganization is the induction of Otx2, a transcription factor whose overexpression is sufficient to induce the primed pluripotency network. Oct4 expression is required for Otx2 induction and Oct4 binding increases at an Otx2 enhancer in the primed state (Buecker et al., 2014; Yang et al., 2014) . We thus tested whether loss of SirT1 resulted in increased binding of Oct4 at this enhancer (enhancer 1). Indeed, increased Oct4 binding was observed in SirT1-knockout ESCs and wild-type ESCs treated with the SirT1 inhibitor Ex-527 ( Figure 4A, right) , consistent with the increased expression of Otx2 described above ( Figures 3C and 4C ). SirT1 itself was not found to be enriched at this Otx2 enhancer ( Figure S4C ).
Otx2 directly binds to Oct4 in the primed state and is required for Oct4 reorganization (Yang et al., 2014) . If the upregulation of Otx2 in SirT1-knockout cells is sufficient to induce Oct4 reorganization, we expected those genes that are activated or repressed by Oct4 to be upregulated or downregulated in the context of SirT1 loss. To define genes whose transcripts are activated or repressed by Oct4, we used previously reported Oct4 ChIP sequencing (ChIP-seq) data in the naive and EpiLC states (Buecker et al., 2014) and our RNA-seq expression data in the wild-type naive and primed EpiLC states. Genes activated by Oct4 were defined by increased Oct4 occupancy and increased expression in the primed EpiLC state or decreased Oct4 occupancy and decreased EpiLC expression in the primed EpiLC state. Genes repressed by Oct4 were defined by increased occupancy and decreased expression in the primed EpiLC state or decreased occupancy and increased expression in the primed EpiLC state. We found that genes that were activated or repressed by Oct4 exhibited directionally concordant expression in SirT1-knockout cells ( Figure 4D, left) . These results indicate that loss of SirT1 deacetylase activity may drive naive cells toward the primed state by promoting Oct4 binding at the Otx2 promoter.
Knockdown of Otx2 Restores the Naive Transcription Network in SirT1-Knockout ESCs
To test whether the induction of Otx2 is required for the transition to primed pluripotency networks in the SirT1-knockout ESCs, we employed a short hairpin RNA (shRNA)-mediated silencing approach to downregulate Otx2. Wild-type and SirT1-knockout ESCs were infected with lentivirus expressing Otx2-targeting shRNA or scrambled controls. Three Otx2 constructs consistently reduced Otx2 expression levels in SirT1-knockout cells ( Figure S5A ). RNA-seq analysis on one of these shRNA lines (Otx2-3) also confirmed that Otx2 expression was restored to wild-type levels in SirT1-null ESCs ( Figure 4C) . Downregulation of Otx2 to wild-type levels in SirT1-knockout ESCs was sufficient to rescue the expression levels of canonical markers of primed pluripotency. Genes such as Nanog and Klf2, (B) Luciferase activity of the Oct4 distal and proximal enhancers. Wild-type (blue) and SirT1-knockout (red) ESCs grown in naive or primed conditions after transfection with luciferase reporter constructs driven by the distal (left) or proximal (right) Oct4 enhancer are shown. Figure S4B (Buecker et al., 2014) which are downregulated in the primed state and SirT1-knockout ESCs, were restored to wild-type levels ( Figure 4C ). Conversely, Fgf5, which is induced in the primed state and SirT1-knockout ESCs, also was restored to wild-type levels. These expression changes were confirmed by western blot analysis ( Figure S5B ). Numerous other genes showed a similar pattern of expression ( Figure S4A ). In addition, the distal and proximal enhancer activity of the Oct4 promoter returned to wild-type naive levels in SirT1-knockout Otx2-knockdown ESCs ( Figure S5C ).
Our previous analysis revealed that loss of SirT1 induced transcriptional networks associated with the primed state ( Figures  3A and 3B) . We used this transcriptome data to study the role of Otx2 by first grouping transcripts that were downregulated or upregulated in wild-type primed EpiLCs compared to wildtype naive ESCs (Figures 5A and 5B ). Next we compared the relative expression of SirT1-knockout naive ESCs, which clearly displayed a shift in the direction of primed wild-type EpiLCs (Figures 5A and 5B). We then tested the hypothesis that upregulation of Otx2 was responsible for this shift by knocking down Otx2 in Genes were chosen based on their significant differential expression between the naive ESC and primed EpiLC state. The relative expression of these genes was compared among wild-type ESCs grown in naive conditions, wild-type EpiLCs, SirT1-null ESCs grown in naive conditions, and SirT1-null and Otx2-knockdown ESCs grown in naive conditions. Blue signal indicates low relative expression. Red signal indicates high relative expression. (B) Boxplots of expression changes in SirT1 knockout and SirT1 knockout Otx2 knockdown for genes up-or downregulated during the naive-toprimed EpiLC transition. Genes exhibiting up-or downregulation during the naive and primed EpiLC states were defined in (A). Upregulated genes were defined as exhibiting significant increased expression in the naive state. Downregulated genes were defined as exhibiting significant decreased expression in the naive state. (C) The role of SirT1, Oct4, and Otx2 during the naive-to-primed transition. In the naive state, SirT1 deacetylates Oct4 at naive enhancers (left panels). Naive enhancers are defined as enhancers that are active in the naive state. During the naive-to-primed transition, SirT1 becomes inactive, resulting in the acetylation of Oct4. Acetylated Oct4 binds an Otx2 enhancer and drives Otx2 expression (middle panels). In the primed state, Otx2 binds acetylated Oct4 and directs it to primed enhancers. Primed enhancers are defined as enhancers that are active in the primed state.
SirT1-knockout naive ESCs and analyzing the expression of these transcripts. There was a clear normalization toward the wildtype naive transcriptome profile in these cells ( Figures 5A and 5B) , indicating that the upregulation of Otx2 per se helps drive the shift toward the primed state in SirT1-knockout ESCs.
Otx2 is thought to promote the primed state through the binding and genomic reorganization of Oct4. To test if Otx2 induction is required for Oct4 reorganization in SirT1-knockout ESCs, we analyzed the expression of genes regulated by Oct4 during the naive-to-EpiLC transition. We found that suppression of Otx2 induction in SirT1-knockout ESCs prevented the activation or suppression of these Oct4-regulated genes ( Figure 4D, right) , further supporting the role of Otx2 induction in SirT1-knockout ESCs as a causative factor underlying the shift to the primed state.
DISCUSSION
In this report, we describe a close association between SirT1 and Oct4 in embryonic stem cells, both physically and functionally. First, SirT1 and Oct4 are highly expressed in pluripotent embryonic stem cells and are coordinately turned off during cell differentiation. Second, SirT1 and Oct4 co-immunoprecipitate, and cells lacking SirT1 have hyper-acetylated Oct4, suggesting that Oct4 is a substrate for deacetylation by SirT1 in stem cells. Indeed, expression of SirT1, but not a catalytically inactive mutant, results in Oct4 deacetylation in HEK293 cells. Third, SirT1 and Oct4 co-occupy the same distal enhancer region in the Oct4 promoter, along with Sox2. To probe the functional significance of the SirT1-Oct4 interaction, we took a cue from the fact that SirT1 activity declines during the transition from naive to primed stem cells, and we queried whether SirT1 helps to maintain cells in the naive state. Importantly, knocking out SirT1 in naive cells phenocopies the transition to primed cells, as indicated by the increase in expression of the primed cellinduced proteins, Otx2 and Fgf5, and a decrease in the primed cell-repressed proteins, Nanog, and Klf2. At the genome-wide level, the transcriptome of naive cells is globally shifted toward that of primed cells by knocking out SirT1, further indicating that this Sirtuin helps maintain the naive state. At the molecular level, enhancer sites bound by Oct4 also shift in cells lacking SirT1 to mimic what happens in primed cells. At the Oct4 promoter, Oct4 binding shifts from the distal to the proximal enhancer, as does the relative activities of these two regions. In addition, Oct4 binding to the Otx2 enhancer is greatly elevated by knocking out SirT1, corresponding to a large increase in Otx2 expression.
What is the mechanism by which SirT1 maintains cells in the naive state? A key step in driving cells toward the primed state is the induction of Otx2, which interacts with Oct4 to alter the enhancers bound by this pluripotency factor and to generate the primed transcriptome (Buecker et al., 2014; Yang et al., 2014) . We tested whether induction of Otx2 in SirT1-lacking cells is a key determinant of priming by using shRNA to knock down Otx2 back to the low levels normally observed in wild-type naive cells. This intervention normalized the transcriptome of SirT1-lacking cells back toward that of naive cells, strongly indicating that the induction of Otx2 is required for inducing the primed phenotype in SirT1-lacking cells. Since the acetylation status of Oct4 also is increased in cells lacking SirT1 or in normal primed cells, we suggest a model in which acetylation of Oct4 may facilitate its binding to an Otx2 enhancer to increase its expression, followed by the redistribution of Oct4-Otx2 to enhancer sites to generate the primed transcriptome ( Figure 5C ). In addition, acetylated Oct4 may be a better binding partner for induced Otx2 during priming. Consistent with this model, naive reprogramming efficiency is reduced in SirT1-null cells. We conclude that the inactivation of SirT1 is a driver of Otx2 induction and possibly the binding of Otx2 and Oct4 in the transition from the naive to the primed state ( Figure 5C ).
Our findings are consistent with previous studies, which indicate a role for SirT1 in induced pluripotency (Mu et al., 2015) . Loss of SirT1 decreased reprogramming efficiency of mouse embryonic fibroblasts, an effect that was shown to involve the SirT1-dependent deacetylation of Sox2. While acetylation of both Sox2 (Mu et al., 2015) and Oct4 increases in ESCs lacking SirT1, only Oct4 occupancy of the Otx2 enhancer was significantly elevated, consistent with the model that acetylation of Oct4 may be driving the naive-to-primed transition. However, an important role for Sox2 in this process is certainly possible.
What is the logic in having SirT1 as an important factor in maintaining the naive state of embryonic stem cells? It is clear that naive cells are more robust than primed cells, both in their growth rate and in their ability to contribute to the differentiated cell population in injected blastocycts (Brons et al., 2007; Dodsworth et al., 2015; Tesar et al., 2007) . Indeed, we found that knocking out SirT1 also slowed the growth of naive cells and, by some assays, altered their morphology to resemble primed cells. One key may rest in the fact that SirT1 generally promotes cell survival, for example, by deacetylating and downregulating p53 and, thus, inhibiting programmed cell death. SirT1 is also critical in DNA repair, aiding both single-strand and double-strand repair by multiple mechanisms. We suggest that, as precursors for all the cells of the developed animal, naive cells must be robust in their potential for duplication in a pluripotent state and capacity for differentiation by combining extremely high fidelity of genome maintenance and rapid cell division. These features may be favored by high SirT1 activity in naive cells. Our findings in this report indicate that, surprisingly, these benefits are coupled to the cell fate decision itself between naive and primed cells by the mechanism in Figure 5C . This coupling may be rationalized because it would allow culling of cells with low SirT1 activity from the naive pool and prevent failures in quality control early in development from being incorporated into the composition of the fully developed animal.
To wit, SirT1 may be suitable as a factor that maintains fidelity as well as the naive state of embryonic stem cells because it responds to environment cues, including food availability and stress. It is possible that unfavorable conditions during early stages of development can repress SirT1 activity and impose a developmental checkpoint. For example, toxic environmental agents could trigger DNA damage, activation of PARPs, depletion of NAD, and inactivation of SirT1, thereby imposing a roadblock to continued embryonic development. While speculative, such a mechanism would explain why SirT1 may be an ideal coupler of the naive state to favorable conditions in embryonic stem cells.
The decline in SirT1 activity in the transition of naive to primed wild-type stem cells appears to occur post-translationally. Possible mechanisms include the induction of a SirT1 inhibitor and a reduction in NAD levels, although the known protein inhibitor of SirT1, DBC1, is not induced during this transition. In this case of NAD, we recently have observed that the addition of an NAD precursor can facilitate the conversion of primed cells into naive cells and inhibit the reverse process. In summary, we have shown that SirT1 is an important factor in maintaining the naive state of embryonic stem cells and inhibiting their conversion into primed cells. This control of cell state may increase the potential of naive cells to contribute to the body composition with high fidelity and couple their maintenance to favorable environmental conditions.
EXPERIMENTAL PROCEDURES
Cell Culture, Differentiation Assays, and Otx2 Knockdown Naive mouse ESCs were cultured in N2B27 media containing 2i inhibitors (PD0325901 and CHIR99021) and LIF. ESCs grown in MEF-serum conditions where grown on irradiated DR4 MEFs in media containing 15% fetal bovine serum (FBS) and LIF. Embryoid bodies were formed in 10-cm Costar Ultra Low Attachment (Corning) plates.
Differentiation of naive mouse ESCs to primed EpiLCs was performed as previously described (Buecker et al., 2014; Hayashi et al., 2011) . The mouse ESCs were passaged three to five times in N2B27 2i + LIF and transferred to fibronectin-coated plates. Differentiating cells were stimulated with 12 ng/mL Fgf2 (Invitrogen), 20 ng/mL Activin A (Sigma), and 1% KnockOut Serum Replacement (Invitrogen) for 48 hr. For Otx2 knockdown, ESCs were infected for 24 hr with lentivirus expressing shRNAs targeting Otx2 or scrambled control, and then they were switched to selection media containing 1 mg/mL puromycin for 3-4 days.
Immunocytochemistry
ESCs were grown on coverslips and fixed with fresh 4% paraformaldehyde (Sigma) for 15 min. For antigen retrieval, cells were incubated in PBS with 0.25% Triton X-100 for 10 min. Primary antibody was applied to cells overnight at 4
C. See Table S1 for antibody information.
Western Blot Assays
Whole-cell lysates were collected from ESCs, EpiLCs, and transfected HEK293T cells in radio-immunoprecipitation assay (RIPA) buffer. HEK293T cells were transfected by calcium phosphate using the following plasmids: pCAG-Myc-Oct4-IP (Addgene 13460), pAD-Track FLAG-SIRT1 (Addgene 8438), and pAD-Track FLAG-SIRT1 H355A (Addgene 8439). CoIPs were performed using Pierce's direct coIP kit. See Table S1 for antibody information.
RNA-Seq
RNA was extracted with Trizol and purified using Direct-zol RNA miniprep kit (Zymo Research). RNA-seq libraries were sequenced using the Illumina Hi-seq 2000 platform. FASTQ files were aligned to the NCBI37/mm9 reference genome using the Tophat aligner. The Cuffdiff tool from the Cufflinks package was used to detect differential expression between datasets. Significant differential expression was defined as genes with Cuffdiff q values <0.05 and >2-fold differential expression.
ChIP qPCR
ChIPs were performed using the SimpleChIP Enzymatic Chromatin IP kit (Cell Signaling Technology). All samples were normalized to input for qPCR analysis. See Table S1 for oligo and antibody information.
Oct4 Enhancer Luciferase Reporter Assay
Mouse Oct4 proximal and distal enhancers were cloned into pGL3 as previously characterized (Tesar et al., 2007) . Constructs were co-transfected with pRL-TK (Renilla) using Xfect mouse ESC transfection reagent (Clontech Laboratories) and incubated for 48 hr. Luciferase activity was assessed using the Dual-Glo Luciferase Assay System (Promega). Oct4 enhancer activity (Firefly) was normalized to Renilla.
Statistical Methods
Unpaired two-tailed Student's t tests were used to assess statistical significance for experiments involving qPCR, flow cytometry, luciferase assays, cell growth analysis, and clonogenicity assays. Differential expression within RNA-seq datasets was defined as genes with Cuffdiff q values <0.05 and >2-fold differential expression. Statistical significance of correlated gene expression profiles was assessed by Pearson correlation.
Mice
All animal experiments were performed in accordance with protocols approved the Institutional Animal Care and Use Committee of Massachusetts Institute of Technology. For more detailed descriptions, see the Supplemental Experimental Procedures.
ACCESSION NUMBERS
The accession number for the RNA-seq data reported in this paper is GEO: GSE81494. 
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